Načítá se...
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
BACKGROUND: Patients with type 2 diabetes (T2D) are at increased cardiovascular (CV) risk compared to subjects without diabetes, with some data estimating that CV disease (CVD) risk is doubled in these individuals. Additionally, CVD remains the leading cause of death in patients with T2D, so it is p...
Uloženo v:
| Vydáno v: | Diabetes Metab Syndr Obes |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452802/ https://ncbi.nlm.nih.gov/pubmed/31040709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S188705 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|